Replies to post #394026 on NorthWest Biotherapeutics Inc (NWBO)

[longfellow95]

Even if it did (which is not at all clear), it would only be by about 5%.
Probably about the same as a one year rise in GBM incidence.

[BerkyBaller1947]

The redefinition of Gbm increases the likelihood of stellar efficacy from treatment with DcVacL. But it also has potential benefits along the entire disease spectrum.

[anders2211]

it will increase the efficiency in such a way that L will become SOC. This will then bring such demand that production can for years not catch up . So the small decrease of the patient population will not affect revenue for many years to come.